LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
Gaebel W, Zielasek J (2008): Editorial: Psychiatry as a diagnostic. Eur
Arch Psychiatry Clin Neurosci 258 (Suppl 5): 1
Gaebel W, Zielasek J (2008): Stand der Entwicklung von ICD-11 und
DSM-V. Nervenarzt 79: 376–378
Gaebel W, Zielasek J (2008): Tendenzen in der Revision von ICD-10
und DSM-IV. Brennpunkt Psychiatrie 1: 6–9
Gaebel W, Zielasek J (2008): The DSM-V initiative „Deconstructing
Psychosis“ in the context of Kraepelin’s concept on nosology. European
Archives of Psychiatry and Clinical Neuroscience 258 (Suppl
2): 41–47
Green MF, Penn D, Bentall R, Carpenter W, Gaebel W, Gur R, Kring
A, Park S, Silverstein S, Heinssen R (2008): Social Cognition in
Schizophrenia: NIMH Consensus Meeting on Definitions, Assessment,
and Research Opportunities. Schizophrenia Bull: 34: 1211–
1220
Kessler H, Baye TA, Bach D, Schneider-Axmann T, Supprian T, Hermann
W, Haber M, Multhaup G, Falkai P, Pajonk FG (2008): Intake
of copper has no effect on cognition in patients with mild
Alzheimer’s disease: a pilot phase 2 clinical trial. J Neural Transm
115: 1181–1187
Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel
W, Klosterkoetter J, Heuser I, Maier W, Lemke MR, Rüther
E, Buchkremer G, Gastpar M, Riedel M, Bottlender R, Strauß A,
Möller HJ (2008): Standardized remission criteria in schizophrenia:
descriptive validity and comparability with previously used outcome
measures. Pharmacopsychiatry 41: 190–195
Jäger M, Riedel M, Schmauß M, Pfeiffer H, Laux G, Naber D, Gaebel
W, Klosterkötter J, Schmidt LG, Heuser I, Buchkremer G, Maier W,
Rüther E, Hoff P, Gastpar M, Bottlender R, Strauß A, Möller
H J (2008): Depression during an acute episode of
schizophrenia or schizophreniform disorder and its implication for
treatment outcome. Psychiatry Res 158: 297–305
Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M (2008): Neurophysiological
biomarkers for drug development in schizophrenia.
Nat Rev Drug Discov 7: 68–83
Kahn R, Fleischhacker W, Boter H, Davidson M, Vergouwe Y, Keet IP,
Gheorghe MD, Rybakowski R, Galderisi S, Libiger J, Hummer M,
Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors
N, Riecher-Rössler A, Grobbee D E (2008): Effectiveness of
antipsychotic drugs in first-episode schizophrenia and schizophre-
132
niform disorder: A European randomised clinical trial. The Lancet
371: 1085–1097
Kirschbaum KM, Müller MJ, Malevani J, Mobascher A, Burchardt C,
Piel M, Hiemke C (2008): Serum levels of aripiprazole and dehydroaripiprazole,
clinical response and side effects. World J Biol Psychiatry
9: 212–218
Klingberg S, Hesse K, Herrlich J, Kossow S, Wiedemann G, Wittorf A,
Wölwer W, Buchkremer G (2008): Kognitiv-verhaltenstherapeutische
Behandlung von Negativsymptomatik bei schizophrenen Psychosen
– Hintergrund und Therapiekonzeption der TONES-Studie.
Nervenheilkunde 27: 997–1006
Konrad A, Winterer G (2008): Disturbed structural connectivity in
schizophrenia primary factor in pathology or epiphenomenon?
Schizophrenia Bull 34: 72–92
Lange-Asschenfeldt C, Kojda G (2008): Alzheimer‘s disease, cerebrovascular
dysfunction and the benefits of exercise: from vessels to
neurons. Exp Gerontol 43: 499–504
Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp
J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus
C, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J,
Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H, Maler
JM, Bibl M, Kornhuber J, Wiltfang J (2008): Soluble amyloid precursor
proteins in the cerebrospinal fluid as novel potential biomarkers
of Alzheimer‘s disease: a multicenter study. Mol Psychiatry
15: 138–145
Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann
H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen
F, Schröder J, Schönknecht P, Hampel H, Peters O, Weimer E,
Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM,
Wiltfang J (2008): Multiplexed quantification of dementia biomarkers
in the CSF of patients with early dementias and MCI: A multicenter
study. Neurobiol Aging 29: 812–818
Löffler S, Cordes J, Danos P, Klimke A (2008): Ziprasidone might prevent
life-threatening hypo- and hyperthermia induced by antipsychotics.
German J Psychiatr 1: 126–127
Luckhaus C, Flüß MO, Wittsack HJ, Grass-Kapanke B, Jänner M,
Khalili-Amiri R, Friedrich W, Supprian T, Gaebel W, Mödder U,
Cohnen M (2008): Detection of changed regional cerebral blood
flow in mild cognitive impairment and early Alzheimer‘s dementia
by perfusion weighted magnetic resonance imaging. NeuroImage
40: 495–503
1 INDIGO Study Group: Austria—H Katschnig, M Freidl; Belgium—C Van Audenhove, G Scheerder, A Hwong; Brazil—C Villares, F de Almeida Pimentel, V Janas
Murier, R Tosta, MR Jorge; Bulgaria—G Veshova, G Petrova, V Sotirov, S Vassilev, D Germanov; Canada—R Milev, L Tackaberry; Cyprus—Y Kalakoutas, M Tziong-
ourou; UK—G Thornicroft, D Rose, N Sartorius, E Brohan, A Law, R Church, J Fisher, M Leese, R Willis, A Kumar, A Kassam, G Schmid; Finland—K Wahlbeck,
J Lillqvist, C Tuohimäki; France—JL Roelandt, JY Giordana, N Daumerie; Germany—AE Baumann, H Zäske, J Weber, P Decker, W Gaebel, H-J Möller; Greece—
M Economou, C Gramandani, E Louki, D Kolostoumpis, D Spiliotis, L Yotis; Hungary—J Harangozo; India—R Thara; Italy—C Buizza, A Cicolini, A Lasalvia,
D Maggiolo, A Ricci, G Rossi, M Tansella, M Vittorielli; Lithuania—A Germanavicius, N Markovskaja, V Pazikaite; Malaysia—C Kok Yoon, N Hayati Ali; Netherlands—J
van Weeghel, A Plooy; Norway—JO Johannessen, S Dybvig; Poland—A Bielañska, A Cechnicki, H Kaszynski; Portugal—M Vargas-Moniz, L Filipe;
Romania—R Teodorescu; Slovakia—M Barova; Slovenia—V _vab, M Strbad; Spain—B Reneses, JL Carrasco, JJ Lopez-Ibor; Switzerland—W Rössler, C Lauber;
Tajikistan—A Latypov; Turkey—A Uçok, B Aslantas; USA—Richard Warner.